SoftBank is in advanced talks to acquire DigitalBridge , Bloomberg News reported on Monday, citing people familiar with the matter. ...

Lennar is a forever holding for me.Warren Buffett's company, Berkshire Hathaway, made a rather sizable bet on the housing market earlier this year. The investment firm bought $800 million of Lennar (LEN 0.18%)(LEN.B 0.39%) stock in August while also purchasing $191.5 million of shares in fellow homebuilder D.R. Horton. While Buffett's company would exit its D.R. Horton position a quarter later, Berkshire boosted its stake in Lennar to $910 million. Berkshire Hathaway appears to be making a more short-term b ...

Lights on in skyscrapers and commercial buildings on the skyline of the City of London, UK, on Tuesday, Nov. 18, 2025. U.K. business chiefs urged Chancellor of the Exchequer Rachel Reeves to ease energy costs and avoid raising the tax burden on corporate Britain as she prepares this year's budget.LONDON — European stocks are expected to start the last trading week of the year in flat territory.The U.K.'s FTSE index, Germany's DAX, France's CAC 40, and Italy's FTSE MIB are all seen opening just a touch highe ...

Building on this ADME–PK foundation for small molecules and peptides, Viva applies modality-specific strategies to antibody programs, where FcRn biology becomes a central determinant of pharmacokinetic behavior. A central technical highlight was Viva Biotech's engineered hFcRn/B2M–MDCK Transwell system for antibody transcytosis, developed to generate a cell-based readout of FcRn-mediated transport and to enable time- and dose-dependent transcytosis measurements. Positioned as a cost- and time-efficient appr ...

LOS ANGELES, Dec. 29, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against F5, Inc. ("F5 " or "the Company") (NASDAQ: FFIV ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: Shareholders who purchased shares of FFIV during the ...

Mergers and acquisitions were among big stories last year and they continued to catch the attention of readers in 2025.The three largest insurance brokers — March, Aon and Arthur J. Gallagher — announced or closed multi-billion-dollar acquisitions in 2024. Within the last 12 months, insurance M&A remained a hot topic. But M&A was one of many topics readers of Insurance Journal clicked on and shared this year. Others included: numerous broker-poaching lawsuits; third-party litigation funding; the affect of t ...

The reporting will feature disclosure of the embedded costs of owning funds, including management expense ratios (MERs), trading expense ratios (TERs) and fund expense ratios, which are the sum of MERs and TERs, in both dollar and percentage terms.TCR is intended to provide investors with greater fee transparency. As investors gain awareness of what they’re paying, advisors and firms risk losing clients — unless they can demonstrate their value proposition.“At the end of the day, cost is only an issue when ...

California’s wildfire and homeowners insurance crisis were the most read stories in Insurance Journal’s Western region this year.It was a year that saw several major insurers draw back from writing homeowners policies in the state, prompting the state’s insurance regulator to alter California’s bedrock property/casualty insurance law and offer to fast-track rate hikes. In exchange, insurers agreed to write in riskier parts of the state and consider returning to offering coverage in the stricken state. It ma ...

Stocks that are too expensive to short often wind up with artificially high prices—setting them up for steep price drops. Here's what to do. ...

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston B ...